Anidulafungin Labatec 100 mg, Poudre pour solution à diluer pour perfusion - 5 Swissmedic Key 67756002 Registration Holder Labatec Pharma SA Name Anidulafungin Labatec 100 mg, Poudre pour solution à diluer pour perfusion Date of registration 21.12.2020 Introduction of Sequence 21.12.2020 ATC-Classification Anidulafungin (J02AX06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 08.06. Show package size 5 Index Therapeuticus (Swissmedic) 08.06. Description Swissmedic categorie. A SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price 1912.24 Deductible k.A. Consumer price 2158.75 Feedback FB GTIN 7680677560026 Medication Code Synthetika Pharmacode Disponibility
Composition Praeparatio cryodesiccata: anidulafunginum 100 mg, fructosum 100 mg, mannitolum, polysorbatum 80, acidum tartaricum, natrii hydroxidum corresp. natrium max. 1.91 mg, acidum hydrochloridum, pro vitro. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form Poudre pour solution à diluer pour perfusion Excipiens Active Agent Dose Anidulafunginum 100 mg
BAG: Active Agent Dose Anidulafunginum 100 mg
Inactive agents Dose Acidum Hydrochloridum Tartaric Acid Fructosum 100 mg Mannitol Sodium Hydroxide Polysorbatum 80
Source Data was imported : 12.03.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
